Breastfeeding, soluble CD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: birth cohort study
- 1 August 2005
- journal article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 35 (8), 1014-1021
- https://doi.org/10.1111/j.1365-2222.2005.02298.x
Abstract
Breast milk contains a variety of bioactive substances, among them, soluble CD14 (sCD14), which plays an important role in innate immunity. We analysed data of a large prospective birth cohort study to examine the determinants of sCD14 in breast milk, and investigated whether breastfeeding practice and sCD14 concentrations in breast milk are determinants of the risk of atopic dermatitis (AD) and asthma in children. Eight hundred and three mothers and their newborns were included in this analysis. We measured sCD14 concentrations in breast milk samples collected 6 weeks post-partum. During a 2-year follow-up the cumulative incidences of AD and asthma were recorded. Overall, AD was reported for 20.6% of the 2-year-olds and asthma was reported for 19.6%. We found the lowest incidence of physician-reported AD in children of mothers without a history of atopic diseases if breastfed for 6 to less than 9 months. Furthermore, we found an inverse association between duration of breastfeeding and risk of asthma, which was especially evident in children with mothers without a history of atopic disease (P=0.01). These patterns persisted after control for other factors by multivariate analysis methods. The protective effect of breastfeeding seemed to be synergistic with sCD14 concentrations in breast milk (P for trend 0.0005). The results of this prospective birth cohort study suggest that a longer duration of breastfeeding does decrease the risk for asthma in early childhood, especially in children of mothers without a history of atopic disease. The beneficial effects of breastfeeding might be further supported by high levels of sCD14 in breast milk.Keywords
This publication has 27 references indexed in Scilit:
- Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or bothJournal of Allergy and Clinical Immunology, 2002
- Breastfeeding duration is a risk factor for atopic eczemaClinical & Experimental Allergy, 2002
- Breast-feeding and the onset of atopic dermatitis in childhood: A systematic review and meta-analysis of prospective studiesJournal of the American Academy of Dermatology, 2001
- Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiationProceedings of the National Academy of Sciences of the United States of America, 2001
- Innate ImmunityThe New England Journal of Medicine, 2000
- Evaluation of CD14 in host defenceEuropean Journal of Clinical Investigation, 2000
- Eczema, asthma and allergyEarly Human Development, 1997
- CD14: Cell surface receptor and differentiation markerImmunology Today, 1993
- Endotoxin-neutralizing capacity of soluble CD14Research in Immunology, 1992
- Preventive measures in early childhood allergyJournal of Allergy and Clinical Immunology, 1986